819 related articles for article (PubMed ID: 10331742)
21. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
22. Somatic events unmask recessive cancer genes to initiate malignancy.
Gallie BL; Worton RG
J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
[TBL] [Abstract][Full Text] [Related]
23. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
24. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
[TBL] [Abstract][Full Text] [Related]
25. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
26. [Oncogenes and suppressor genes in the genesis and progression of solid tumors in children].
Tonini GP; Mazzocco K; Scaruffi P
Pediatr Med Chir; 1994; 16(3):203-9. PubMed ID: 7971441
[TBL] [Abstract][Full Text] [Related]
27. Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids.
Mendonca MS; Antoniono RJ; Latham KM; Stanbridge EJ; Redpath JL
Cancer Res; 1991 Aug; 51(16):4455-62. PubMed ID: 1868467
[TBL] [Abstract][Full Text] [Related]
28. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
29. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
Cote RJ; Jhanwar SC; Novick S; Pellicer A
Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
[TBL] [Abstract][Full Text] [Related]
30. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay.
Conway K; Morgan D; Phillips KK; Yuspa SH; Weissman BE
Cancer Res; 1992 Dec; 52(23):6487-95. PubMed ID: 1358434
[TBL] [Abstract][Full Text] [Related]
31. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
32. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
33. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
34. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
35. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
[TBL] [Abstract][Full Text] [Related]
36. Altered response of a human squamous cell carcinoma cell line to 1, 25-dihydroxyvitamin D(3) after transfer of a normal chromosome 11.
Merrihew RV; Cruickshank RD; Conway K; Weissman BE
Exp Cell Res; 2000 Aug; 259(1):191-203. PubMed ID: 10942591
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms for inactivation of tumor suppressor genes].
Ishizaki K
Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
Bièche I; Lidereau R
Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
[TBL] [Abstract][Full Text] [Related]
40. The involvement of oncogenes and suppressor genes in human neoplasia.
Brodeur GM
Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]